Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019.


Journal

The Lancet. Planetary health
ISSN: 2542-5196
Titre abrégé: Lancet Planet Health
Pays: Netherlands
ID NLM: 101704339

Informations de publication

Date de publication:
05 2023
Historique:
received: 16 07 2022
revised: 08 03 2023
accepted: 10 03 2023
medline: 12 5 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

Air pollution is the sixth highest risk factor for attributable disability-adjusted life-years (DALYs) in North Africa and the Middle East, but the relative importance of different subtypes of air pollution and any potential differences in their health effects by population demographics or country-level socioeconomic factors have not been fully explored. The objective of this study was to investigate the effect of high ambient particulate matter less than 2·5 μm in size (PM) and ambient ozone air pollution on disease burden, mortality, and life expectancy in 21 countries in the North Africa and the Middle East super-region from 1990 to 2019 using the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates. The study data were derived from GBD 2019, examining data from 1999 to 2019 in North Africa and the Middle East. In this study, the types of air pollution investigated included PM pollution and ambient ozone pollution. PM pollution itself was categorised as household air pollution from solid fuels and ambient PM pollution. The burden attributable to each risk factor, directly or indirectly, was incorporated in the population attributable fraction to estimate the total attributable deaths and DALYs. The summary exposure value (SEV) as the relative risk-weighted prevalence of exposure was extracted to compare the distribution of excess risk times the exposure level in a population where everyone is at maximum risk and ranges from zero (no excess risk exists in a population) to 100 (highest risk). The effect of air pollution on life expectancy was estimated via a cause-deleted life table analysis. The age-standardised DALYs rate attributable to air pollution declined by 44·5%, from 4884·2 (95% uncertainty interval 4381·5-5555·4) to 2710·4 (2317·3-3125·6) per 100 000 from 1990 to 2019. Afghanistan (6992·3, 5627·7-8482·7), Yemen (4212·4, 3241·3-5418·1), and Egypt (4034·8, 3027·7-5138·6) had the highest age-standardised DALYs rates attributable to air pollution in 2019 per 100 000, whereas Türkiye (1329·2, 1033·7-1654·7), Jordan (1447·3, 1154·2-1758·5), and Iran (1603·0, 1404·7-1813·8) had the lowest rates. During the study period, the age-standardised SEV of air pollution (PM and ambient ozone in total) decreased by 10·9% (5·8-17·7%) in the super-region, whereas the SEV of ambient ozone pollution alone increased by 7·7% (0·7-14·3%). Among the components of PM pollution, the SEV of ambient PM pollution increased by 40·1% (25·2-63·7%); however, the SEV of household air pollution from solid fuels decreased by 70·6% (64·1-77·0%). Among the investigated types of air pollution, 98·9% of the DALYs from air pollution in the super-region were attributable to PM pollution. If air pollution had been lowered to the theoretical minimum risk exposure levels for 2019, then the average life expectancy would have been 1·6 years higher. The burden attributable to air pollution substantially decreased in the study period across the super-region as a whole. Most of the burden from air pollution is attributed to PM pollution, the exposure to which has substantially increased in the past three decades. Interventions and policies that reduce population exposure to PM pollution could potentially increase the average life expectancy in the super-region. This finding calls for concerted efforts from governments and public health authorities in the super-region to tackle air pollution as an important threat to population health. Bill & Melinda Gates Foundation.

Sections du résumé

BACKGROUND
Air pollution is the sixth highest risk factor for attributable disability-adjusted life-years (DALYs) in North Africa and the Middle East, but the relative importance of different subtypes of air pollution and any potential differences in their health effects by population demographics or country-level socioeconomic factors have not been fully explored. The objective of this study was to investigate the effect of high ambient particulate matter less than 2·5 μm in size (PM) and ambient ozone air pollution on disease burden, mortality, and life expectancy in 21 countries in the North Africa and the Middle East super-region from 1990 to 2019 using the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates.
METHODS
The study data were derived from GBD 2019, examining data from 1999 to 2019 in North Africa and the Middle East. In this study, the types of air pollution investigated included PM pollution and ambient ozone pollution. PM pollution itself was categorised as household air pollution from solid fuels and ambient PM pollution. The burden attributable to each risk factor, directly or indirectly, was incorporated in the population attributable fraction to estimate the total attributable deaths and DALYs. The summary exposure value (SEV) as the relative risk-weighted prevalence of exposure was extracted to compare the distribution of excess risk times the exposure level in a population where everyone is at maximum risk and ranges from zero (no excess risk exists in a population) to 100 (highest risk). The effect of air pollution on life expectancy was estimated via a cause-deleted life table analysis.
FINDINGS
The age-standardised DALYs rate attributable to air pollution declined by 44·5%, from 4884·2 (95% uncertainty interval 4381·5-5555·4) to 2710·4 (2317·3-3125·6) per 100 000 from 1990 to 2019. Afghanistan (6992·3, 5627·7-8482·7), Yemen (4212·4, 3241·3-5418·1), and Egypt (4034·8, 3027·7-5138·6) had the highest age-standardised DALYs rates attributable to air pollution in 2019 per 100 000, whereas Türkiye (1329·2, 1033·7-1654·7), Jordan (1447·3, 1154·2-1758·5), and Iran (1603·0, 1404·7-1813·8) had the lowest rates. During the study period, the age-standardised SEV of air pollution (PM and ambient ozone in total) decreased by 10·9% (5·8-17·7%) in the super-region, whereas the SEV of ambient ozone pollution alone increased by 7·7% (0·7-14·3%). Among the components of PM pollution, the SEV of ambient PM pollution increased by 40·1% (25·2-63·7%); however, the SEV of household air pollution from solid fuels decreased by 70·6% (64·1-77·0%). Among the investigated types of air pollution, 98·9% of the DALYs from air pollution in the super-region were attributable to PM pollution. If air pollution had been lowered to the theoretical minimum risk exposure levels for 2019, then the average life expectancy would have been 1·6 years higher.
INTERPRETATION
The burden attributable to air pollution substantially decreased in the study period across the super-region as a whole. Most of the burden from air pollution is attributed to PM pollution, the exposure to which has substantially increased in the past three decades. Interventions and policies that reduce population exposure to PM pollution could potentially increase the average life expectancy in the super-region. This finding calls for concerted efforts from governments and public health authorities in the super-region to tackle air pollution as an important threat to population health.
FUNDING
Bill & Melinda Gates Foundation.

Identifiants

pubmed: 37164512
pii: S2542-5196(23)00053-0
doi: 10.1016/S2542-5196(23)00053-0
pmc: PMC10186179
pii:
doi:

Substances chimiques

Ozone 66H7ZZK23N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e358-e369

Investigateurs

Mohsen Abbasi-Kangevari (M)
Mohammad-Reza Malekpour (MR)
Masoud Masinaei (M)
Sahar Saeedi Moghaddam (S)
Seyyed-Hadi Ghamari (SH)
Zeinab Abbasi-Kangevari (Z)
Negar Rezaei (N)
Nazila Rezaei (N)
Amirali Aali (A)
Sina Abdollahzade (S)
Salam Abdulqadir Abdulrahman (SA)
Hiwa Abubaker Ali (H)
Aqeel Ahmad (A)
Rizwan Ahmad (R)
Ali Ahmadi (A)
Mohammad Ahmadian (M)
Haroon Ahmed (H)
Tarik Ahmed Rashid (T)
Marjan Ajami (M)
Hanadi Al Hamad (H)
Fadwa Alhalaiqa Naji Alhalaiqa (FAN)
Vahid Alipour (V)
Sami Almustanyir (S)
Javad Aminian Dehkordi (J)
Sohrab Amiri (S)
Jalal Arabloo (J)
Judie Arulappan (J)
Zahra Aryan (Z)
Seyyed Shamsadin Athari (SS)
Sina Azadnajafabad (S)
Nayereh Baghcheghi (N)
Farshad Bahrami Asl (F)
Ovidiu Constantin Baltatu (OC)
Azadeh Bashiri (A)
Akshaya Srikanth Bhagavathula (AS)
Ali Bijani (A)
Saeid Bitaraf (S)
Michael Brauer (M)
Maria Cheraghi (M)
Saad M A Dahlawi (SMA)
Abdollah Dargahi (A)
Reza Darvishi Cheshmeh Soltani (R)
Mostafa Dianatinasab (M)
Milad Dodangeh (M)
Ebrahim Eini (E)
Maysaa El Sayed Zaki (M)
Hassan El-Abid (H)
Muhammed Elhadi (M)
Sharareh Eskandarieh (S)
Shahab Falahi (S)
Mohammad Fareed (M)
Ali Fatehizadeh (A)
Mehdi Fazlzadeh (M)
Farhad Ghamari (F)
Reza Ghanbari (R)
Ahmad Ghashghaee (A)
Abdolmajid Gholizadeh (A)
Mohamad Golitaleb (M)
Gholamreza Goudarzi (G)
Mostafa Hadei (M)
Randah R Hamadeh (RR)
Samer Hamidi (S)
Ahmed I Hasaballah (AI)
Hamidreza Hasani (H)
Soheil Hassanipour (S)
Kamal Hezam (K)
Mohammad Hoseini (M)
Mohammad-Salar Hosseini (MS)
Mehdi Hosseinzadeh (M)
Soodabeh Hoveidamanesh (S)
Jalil Jaafari (J)
Hosna Janjani (H)
Sathish Kumar Jayapal (SK)
Laleh R Kalankesh (LR)
Rohollah Kalhor (R)
Samad Karkhah (S)
Neda Kaydi (N)
Yousef Saleh Khader (YS)
Morteza Abdullatif Khafaie (MA)
Javad Khanali (J)
Moawiah Mohammad Khatatbeh (MM)
Ali Koolivand (A)
Mohammed Kuddus (M)
Faris Hasan Lami (FH)
Soleiman Mahjoub (S)
Afshin Maleki (A)
Ahmad Azam Malik (AA)
Sahar Masoudi (S)
Ritesh G Menezes (RG)
Shabir Ahmad Mir (SA)
Ashraf Mohamadkhani (A)
Esmaeil Mohammadi (E)
Mohammad Javad Mohammadi (MJ)
Mokhtar Mohammadi (M)
Fateme Montazeri (F)
Paula Moraga (P)
Negar Morovatdar (N)
Christopher J L Murray (CJL)
Abbas Norouzian Baghani (A)
Keyvan Pakshir (K)
Hamidreza Pazoki Toroudi (H)
Meghdad Pirsaheb (M)
Ashkan Pourabhari Langroudi (A)
Fakher Rahim (F)
Mehran Rahimi (M)
Shayan Rahmani (S)
Sina Rashedi (S)
Azad Rasul (A)
Elrashdy Moustafa Mohamed Redwan (EMM)
Mohsen Rezaeian (M)
Saeid Sadeghian (S)
Amirhossein Sahebkar (A)
Mohammad Ali Sahraian (MA)
Payman Salamati (P)
Hedayat Salari (H)
Abdallah M Samy (AM)
Brijesh Sathian (B)
Kiomars Sharafi (K)
Ali Sheikhy (A)
Parnian Shobeiri (P)
Zahra Shokri Varniab (Z)
Seyed Afshin Shorofi (SA)
Ensiyeh Taheri (E)
Sahel Valadan Tahbaz (S)
Siavash Vaziri (S)
Mehdi Vosoughi (M)
Kheirollah Yari (K)
Arzu Yigit (A)
Vahit Yigit (V)
Leila Zaki (L)
Iman Zare (I)
Ahmad Zarei (A)
Zahra Zareshahrabadi (Z)
Ali H Mokdad (AH)
Mohsen Naghavi (M)
Bagher Larijani (B)
Farshad Farzadfar (F)

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Environ Res. 2021 Mar;194:110703
pubmed: 33417909
Lancet Planet Health. 2019 Jan;3(1):e26-e39
pubmed: 30528905
Environ Res. 2020 Jan;180:108817
pubmed: 31627156
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Lancet Planet Health. 2022 Jul;6(7):e586-e600
pubmed: 35809588
Lancet. 2018 Oct 27;392(10157):1502-1503
pubmed: 30496047
Stat Med. 1987 Jun;6(4):527-8
pubmed: 3629053
Am J Respir Crit Care Med. 2016 May 15;193(10):1134-42
pubmed: 26680605
Environ Health Perspect. 2013 Jul;121(7):784-90
pubmed: 23674502
Nature. 2020 Feb;578(7794):261-265
pubmed: 32051602
Cardiovasc Res. 2020 Feb 1;116(2):279-294
pubmed: 31583404
PLoS Med. 2021 Sep 28;18(9):e1003718
pubmed: 34582444
Lancet. 2017 May 13;389(10082):1907-1918
pubmed: 28408086
Environ Int. 2020 Nov;144:106015
pubmed: 32858467
Popul Health Metr. 2003 Apr 14;1(1):1
pubmed: 12780936
Lancet. 2021 Jan 9;397(10269):129-170
pubmed: 33278353
Sci Total Environ. 2020 Jan 10;699:134403
pubmed: 31678873
Int J Chron Obstruct Pulmon Dis. 2016 Dec 12;11:3079-3091
pubmed: 28003742
Toxicol Res. 2014 Jun;30(2):71-5
pubmed: 25071915
Chronic Dis Can. 2003 Fall;24(4):108-15
pubmed: 14733760
Epidemiology. 2013 Jan;24(1):23-31
pubmed: 23211349

Auteurs

Mohsen Abbasi-Kangevari (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad-Reza Malekpour (MR)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Masoud Masinaei (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Sahar Saeedi Moghaddam (SS)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Kiel Institute for the World Economy, Kiel, Germany.

Seyyed-Hadi Ghamari (SH)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Zeinab Abbasi-Kangevari (Z)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Negar Rezaei (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Nazila Rezaei (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ali H Mokdad (AH)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.

Mohsen Naghavi (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.

Bagher Larijani (B)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Farshad Farzadfar (F)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: f-farzadfar@tums.ac.ir.

Christopher J L Murray (CJL)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.

Articles similaires

Humans Blindness Male Female Cross-Sectional Studies
Humans Male Female Cross-Sectional Studies Middle Aged

Burden and causes of anemia in Vietnam: insights from the global burden of disease data.

Deepak Kumar Behera, Dil B Rahut, Snehasish Tripathy et al.
1.00
Humans Vietnam Female Anemia Male

Classifications MeSH